Cerebrovascular Assessment for the Risk Prediction of Alzheimer's Disease

被引：30

作者：

Silvestrini, Mauro ^{[1
]}

Viticchi, Giovanna ^{[1
]}

Altamura, Claudia ^{[2
]}

Luzzi, Simona ^{[1
]}

Balucani, Clotilde ^{[3
]}

Vernieri, Fabrizio ^{[2
]}

机构：

[1] Univ Politecn Marche, Neurol Clin, I-60020 Ancona, Italy

[2] Campus Biomed Univ, Neurol Clin, Rome, Italy

[3] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2012年 / 32卷 / 03期

关键词：

Alzheimer's disease; vascular markers; vascular risk factors; WHITE-MATTER LESIONS; MILD COGNITIVE IMPAIRMENT; INTIMA-MEDIA THICKNESS; CEREBRAL VASOMOTOR REACTIVITY; GLYCATION END-PRODUCTS; MIDLIFE BLOOD-PRESSURE; APOLIPOPROTEIN-E; CAROTID ATHEROSCLEROSIS; AMYLOID-BETA; ATRIAL-FIBRILLATION;

D O I：

10.3233/JAD-2012-121240

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Increasing evidence is emerging that vascular disease and its risk factors play a role in the development of Alzheimer's disease (AD) and affect the probability of an adverse outcome. The aims of this review are to explore the relationship between vascular risk factors and AD and to discuss the potential use of vascular markers in the clinical approach to cognitive impairment. Moreover, we present evidence about the potential use of ultrasonographic and neuroradiologic markers of cognitive impairment in order to establish possible treatment strategies in subjects with a clinical profile at risk of developing AD.

引用

页码：689 / 698

页数：10

共 50 条

[41] The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease
Pimentel-Coelho, Pedro M.
Rivest, Serge
EUROPEAN JOURNAL OF NEUROSCIENCE, 2012, 35 (12) : 1917 - 1937
[42] Fast Declining Prediction in Alzheimer's Disease from Early Clinical Assessment
Alvarez-Sanchez, Lourdes
Pereto, Mar
Garcia-Valles, Lorena
Balaguer, Angel
Pena-Bautista, Carmen
Ferre-Gonzalez, Laura
Baquero, Miguel
Pericas, Consuelo Chafer
CURRENT NEUROPHARMACOLOGY, 2025, 23 (05) : 602 - 611
[43] Cerebral Hemodynamics and Vascular Risk Factors: Setting the Stage for Alzheimer's Disease
de la Torre, Jack C.
JOURNAL OF ALZHEIMERS DISEASE, 2012, 32 (03) : 553 - 567
[44] Mixed dementia: Alzheimer's and cerebrovascular disease
Rockwood, K
INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 39 - 46
[45] Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease
Grossmann, Klaus
BIOMEDICINES, 2022, 10 (08)
[46] Medication Exposure and Risk of Dementia and Alzheimer's Disease
Sharma, Niti
An, Seong Soo A.
Kim, Sang Yun
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
[47] Oxidant/Antioxidant Imbalance and the Risk of Alzheimer's Disease
Abdel Moneim, Ahmed E.
CURRENT ALZHEIMER RESEARCH, 2015, 12 (04) : 335 - 349
[48] Value and acceptance of risk assessment for Alzheimer's disease
Bartzsch, O.
Gertheiss, J.
Calabrese, P.
NERVENARZT, 2015, 86 (12): : 1549 - 1554
[49] Are cerebrovascular factors involved in Alzheimer's disease?
Kudo, T
Imaizumi, K
Tanimukai, H
Katayama, T
Sato, N
Nakamura, Y
Tanaka, T
Kashiwagi, Y
Jinno, Y
Tohyama, M
Takeda, M
NEUROBIOLOGY OF AGING, 2000, 21 (02) : 215 - 224
[50] Influence of cerebrovascular disease on brain networks in prodromal and clinical Alzheimer's disease
Chong, Joanna Su Xian
Liu, Siwei
Loke, Yng Miin
Hilal, Saima
Ikram, Mohammad Kamran
Xu, Xin
Tan, Boon Yeow
Venketasubramanian, Narayanaswamy
Chen, Christopher Li-Hsian
Zhou, Juan
BRAIN, 2017, 140 : 3012 - 3022

← 1 2 3 4 5 →